- Home
- ZJYL vs DYAI Comparison
ZJYL vs DYAI Comparison
Compare ZJYL & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZJYL | DYAI |
|---|---|---|
| Founded | 2006 | 1979 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.7M | 29.9M |
| IPO Year | 2023 | 2004 |
Fundamental Metrics
Financial Performance| Metric | ZJYL | DYAI |
|---|---|---|
| Price | $0.16 | $0.86 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | ★ 1.3M | 55.6K |
| Earning Date | 08-20-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $22,826,624.00 | $3,342,195.00 |
| Revenue This Year | N/A | $12.52 |
| Revenue Next Year | N/A | $92.04 |
| P/E Ratio | $13.19 | ★ N/A |
| Revenue Growth | ★ 13.42 | N/A |
| 52 Week Low | $0.11 | $0.71 |
| 52 Week High | $1.03 | $1.73 |
Technical Indicators
Market Signals| Indicator | ZJYL | DYAI |
|---|---|---|
| Relative Strength Index (RSI) | 39.35 | 40.23 |
| Support Level | $0.12 | $0.87 |
| Resistance Level | $0.18 | $0.95 |
| Average True Range (ATR) | 0.03 | 0.04 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 30.12 | 8.77 |
Price Performance
Historical ComparisonAbout ZJYL JIN MEDICAL INTERNATIONAL LTD.
Jin Medical International Ltd offers rehabilitation equipment. It is engaged in the design, development, manufacturing, and sales of wheelchairs and other living aids products to be used by people with disabilities or impaired mobility. The company's products are sold to distributors in both China and overseas markets. Its product offerings comprise Wheelechaire serirs, Bath products, oxygen machines, and nursing products. Geographically, it generates the majority of its revenue from Japan.
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.